Table 3 Odds ratio for completion of curative-intent guideline-concordant treatment (GCT) among a prospective cohort of Malawian women with breast cancer, December 2016-October 2018
Total (n = 65) | Unadjusted OR (95% CI) | p value | Adjusted OR (95% CI)a | p value |
|---|---|---|---|---|
Age | 0.99 (0.95–1.02) | 0.53 |  |  |
Residence | Â | Â | Â | Â |
Lilongwe | 1 (Ref) | Â | ||
Outside Lilongwe | 0.85 (0.22–3.18) | 0.8 | ||
Occupation | Â | Â | Â | Â |
Employed full time | 1 (Ref) | Â | ||
Employed part time | 0.66 (0.92–4.81) | 0.68 | ||
Housewife | 0.45 (0.11–1.78) | 0.26 | ||
Unemployed | 0.33 (0.05–1.85) | 0.21 | ||
Other | 0.53 (0.11–2.41) | 0.41 | ||
HIV Status | Â | Â | Â | Â |
Negative | 1 (Ref) | Â | Â | Â |
Positive | 0.25 (0.06–0.99) | 0.049* | 0.17 (0.03–1.02) | 0.053** |
Stage | Â | Â | Â | Â |
II | 1 (Ref) | Â | 1 (Ref) | Â |
III | 0.10 (0.01–0.89)* | 0.040* | 0.26 (0.02–2.76) | 0.26 |
Tumor > 5cm |  |  |  |  |
Yes | 0.73 (0.25-2.0) | 0.56 | ||
No | 1 (Ref) | Â | ||
ER/PR+/HER2- | 1 (Ref) | Â | 1 (Ref) | Â |
ER/PR+/HER2+ | 0.45 (0.03–6.05) | 0.5 | 0.36 (0.02–5.65) | 0.46 |
ER/PR-/HER2+ | 0.07 (0.01–0.49)* | 0.007* | 0.12 (0.01–0.97)* | 0.047* |
ER/PR-/HER2- | 0.49 (0.12–1.93) | 0.31 | 0.60 (0.12–2.90) | 0.53 |
Unable to assess | 0.11 (0.01–1.51)** | 0.10** | 0.37 (0.02–6.87) | 0.51 |